WBD adds litigation firepower in Silicon Valley with DLA Piper veteran

Womble Bond Dickinson has expanded its West Coast footprint with the addition of a seasoned patent litigator, strengthening the firm’s life sciences capabilities amid rising IP disputes and rapid biotech innovation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Norton Rose Fulbright expands pharma and biotech disputes team

13 February 2026 The firm recruits two Cooley partners with expertise in Hatch-Waxman, BPCIA, trade secrets, and competitor versus competitor patent litigation.

Careers

Honigman bags second Kirkland litigator this year for IP team

12 February 2026 New Bloomfield Hills partner handles patent, trade secrets, and contracts disputes, and marks the sixth partner to join the firm in 2026.

Careers

Wilson Sonsini senior counsel moves to a rival firm

6 February 2026 The New York-based partner will advise biotech, pharma, and technology clients on patent prosecution, IP strategy and venture-backed transactions.

More features

New rankings recognise top US patent firms and lawyers

Norton Rose Fulbright expands pharma and biotech disputes team

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents

Honigman bags second Kirkland litigator this year for IP team

Reaction: Emotional Perception decision is ‘good for UK PLC’

UK ruling ‘future-proofs’ patentability for AI and computer tech

The curtain closes on three major drug disputes

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’

WBD adds litigation firepower in Silicon Valley with DLA Piper veteran

More on this story

Editor's picks

Editor's picks

More features